Boston Scientific Corporation (BSX) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Devices industria. La empresa tiene su sede en Marlborough, MA, United States. El CEO actual es Michael F. Mahoney.
BSX tiene fecha de IPO 1992-05-19, 53,000 empleados a tiempo completo, cotiza en el NYSE, una capitalización de mercado de $94.85B.
Boston Scientific Corporation is a global medical device manufacturer that develops, manufactures, and markets innovative devices across interventional medical specialties. Operating through three primary segments—MedSurg, Rhythm and Neuro, and Cardiovascular—the company serves diverse therapeutic areas including gastrointestinal and pulmonary diagnostics, urology, cardiac rhythm management, neurostimulation, and interventional cardiology. Its comprehensive product portfolio encompasses implantable cardiac devices, ablation systems, coronary stents, peripheral vascular interventions, and oncology treatment solutions. Headquartered in Marlborough, Massachusetts, Boston Scientific has established itself as a leading provider of minimally invasive medical technologies that improve patient outcomes across multiple healthcare markets worldwide.
